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The detection of Rickettsia akari in 2 human patients 
increased the diversity of rickettsioses affecting the public 
health in the southeast of Mexico. Rickettsialpox should be 
considered in the differential diagnosis with other febrile ill-
nesses for the correct diagnosis and accurate treatment of 
this potential threat to human health.
R
ickettsialpox is an illness characterized by fever, head-
ache, papulovesicular rash over the trunk and extremi-
ties, and, in 80% of cases, appearance of an eschar. Rickett-
sia akari, the etiologic agent of rickettsialpox, is commonly 
transmitted by the bite of the house-mouse mite, Liponys-
soides sanguineus. Human cases of rickettsialpox, as well 
as infected mites and potential reservoirs of R. akari, have 
been found in several countries, including the United States, 
Turkey, Croatia, and Ukraine (1–5). Despite the presence 
of the house mouse (Mus musculus) around the world, in 
Latin America human cases caused by R. akari have not 
been reported, and rickettsial diseases caused by antigeni-
cally related rickettsiae have been confined to R. rickettsii, 
R. felis, R. prowasekii, R. typhi, and R. parkeri (6–11). We 
report 2 human cases of R. akari infection in the Yucatan 
Peninsula of Mexico.
The Study
Patient 1 was a 9-year-old girl who came to the public 
hospital in Merida, Yucatan, in May 2008. Her illness had 
started abruptly with high fever and headache, then evolved 
over a 12-day period to include nausea, vomiting, hemor-
rhagic conjunctivitis, excessive lacrimation, and epistaxis. 
She was treated empirically with antipyretic drugs and had 
a slight improvement; 3 days after beginning treatment, fe-
ver and epistaxis returned with myalgia; irritability; papu-
lovesicular rash involving the extremities, thorax, and oral 
mucosa; vaginal and gingival bleeding; and disseminated 
ecchymoses. Clinical laboratory studies showed hemoglo-
bin 9.9 g/dL and hematocrit 29.0% (reference ranges 12–18 
g/dL and 31%–51%, respectively), thrombocytopenia (45 
× 103 platelets/mL [reference range 140–440 × 103 plate-
lets/mL]),  prolonged  prothrombin  and  thromboplastine 
times (20 s and 64 s [reference range 10–15 s and 25–35 
s, respectively]), neutrophilia, and elevated transaminase   
levels (aspartate transaminase 100 mU/mL [reference range 
14–36 mU/mL], alanine transaminase 148 mU/mL [refer-
ence range 9–52 mU/mL]). The girl was hospitalized in the 
intensive care unit with a preliminary diagnosis of shock 
from dengue hemorrhagic fever.
Patient 2 was a 32-year-old woman in whom rickett-
sialpox was diagnosed in July 2008. She reported visiting 
a suburban area and being bitten by an unidentified arthro-
pod. Her illness started abruptly with fever, headache, my-
algia, and arthralgia in her extremities. The patient showed 
signs of dengue fever and was treated symptomatically. 
Three days after the first symptoms, a papulovesicular rash 
appeared on her extremities and thorax. Clinical laboratory 
results showed thrombocytopenia (100 × 103 platelets/mL 
[reference range 140–440 × 103 platelets/mL]) with slightly 
prolonged clotting times of thrombin and prothrombin, and 
neutrophilia.
Rickettsiosis  was  diagnosed  on  the  basis  of  PCR 
amplification  and  sequencing  of  bacterial  genes;  immu-
nofluorescent assay (IFA) and restriction fragment length 
polymorphism  (RFLP)  analyses  confirmed  the  diagno-
sis and identified the Rickettsia species. Blood was col-
lected in 3.8% sodium citrate as anticoagulant, and DNA 
was extracted immediately by QIAamp DNA kit (QIA-
GEN, Valencia, CA, USA) following the manufacturer’s 
instructions.  PCR  amplification  was  performed  by  us-
ing genus-specific primers for the rickettsial 17-kDa pro-
tein  gene  (5′-GCTCTTGCAACTTCTATGTT-3′  and 
5′-CATTGTTCGTCAGGTTGGCG-3′)  (434-bp  PCR 
fragment) and the outer membrane protein B (ompB) prim-
ers  (5′-ATGGCTCAAAAACCAAATTTTCTAA-3′  and 
5′-GCTCTACCTGCTCCATTATCTGTACC-3′)  (996-bp 
PCR fragment). The positive controls used were DNA of 
R. felis, R. rickettsii, R. akari, R. typhi, R. conorii, and R. 
honei, provided by the Rickettsial and Ehrlichial Diseases 
Research Laboratory (University of Texas Medical Branch, 
Galveston, TX, USA); 1 reaction without DNA was used 
as a negative control. To avoid contamination, DNA of the 
positive controls and the patients was handled separately.
PCR products from the 17-kDa PCR were digested 
with  the  AluI  (Invitrogen,  Carlsbad,  CA,  USA)  restric-
tion enzyme (Figure). Sequences of the ompB PCR and 
17-kDa products were compared at the National Center 
for Biotechnology Information by using the BLAST soft-
ware (12). The ompB sequence showed 100% identity with 
R. akari (GenBank accession no. CP000847), 92% with   
R. australis (GenBank accession no. AF123709.1), 90% 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 10, October 2009  1665 
Author  affiliation:  Universidad  Autónoma  de  Yucatán,  Mérida,   
México
DOI: 10.3201/eid1510.081507with R. felis (GenBank accession no. CP000053.1), and 
<90%  with  other  Rickettsia  spp.  The  17-kDa  sequence 
showed 100% identity with R. akari (GenBank accession 
no. CP000847.1), and <95% with R. rickettsii (GenBank 
accession no. CP000848.1), R. conorii (GenBank acces-
sion no. AE006914.1), and other Rickettsia spp.
IFA showed that both patients had moderate antibody 
titers reactive with R. akari (patient 1, 256; patient 2, 128), 
low antibody titers reactive with R. rickettsii (patient 1, 64; 
patient 2, 32), and no antibodies to R. typhi antigens. A 
positive human serum control and IFA slides were provid-
ed by Rickettsial and Ehrlichial Diseases Research Labora-
tory. We detected immunoglobulin M by using a μ heavy 
chain–specific conjugate. Only an acute serum sample was 
collected from each patient during the 12–21 days after ill-
ness onset. Positive serum samples were serially diluted to 
1:4,096 to determine the endpoint titer.
Patient 1 was treated with intravenous chlorampheni-
col, 75 mg/kg 1× per day for 7 days; clinical signs were 
reduced in 36 hours. Both patients were treated with 100 
mg of oral doxycycline 2× per day for 7 days; symptoms 
were reduced in 48–72 hours.
Conclusions
Human rickettsioses have tremendously affected pub-
lic health in the Americas. In the past decade, several Latin 
American countries have reported infected vectors, potential 
reservoirs, and human cases of rickettsial infections. Human 
cases have been limited to infections with R. rickettsii, R. 
felis, R. prowasekii, R. typhi, and R. parkeri (6–11). In south-
eastern Mexico, R. rickettsii and R. felis have been the only 
rickettsiae detected for many years; several cases of human 
illness and even deaths have occurred (6,8).
Rickettsialpox is a benign, self-limiting disease that 
usually resolves within 14–21 days; no deaths from rickett-
sialpox have been reported. However, for 1 of our patients, 
hemorrhage was the most prominent sign; the severity of 
the clinical features could have caused death had the correct 
treatment not been instituted promptly. Although hemor-
rhages have not been described for rickettsialpox, dissimi-
larities in the clinical features of rickettsial disease among 
countries have been reported (13). Organ infections caused 
by  increased  vascular  permeability  have  been  described 
in rickettsial infections with different degrees of severity. 
Rickettsialpox has even been associated with hepatitis, a 
not well-documented complication of rickettsialpox (14).
The similarity among symptoms of rickettsial infections 
and other febrile illnesses endemic to Yucatan, such as den-
gue fever, and the continuous environmental exposures of 
rural inhabitants to vectors of rickettsial diseases encouraged 
us to implement epidemiologic surveillance. Our 2 patients 
were detected by this surveillance. Both patients came from 
the relatively close rural areas of Yucatan and Campeche, 
Mexico, and reported mice near their homes.
Although our patients did not have eschars, we diag-
nosed the infection as R. akari serologically and molecu-
larly. However, if IFA gives inconclusive results, PCR am-
plification of the bacterial genome is the decisive parameter 
for diagnosis. Our report of these 2 human rickettsialpox 
cases in Mexico provides a new rickettsial infection to con-
sider in the differential diagnosis of febrile illnesses.
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Figure. Restriction fragment length polymorphism of the 17-kDa 
PCR product (434 bp) digested with AluI. Top: lane 1, 32-year-old 
woman;  lane  2,  9-year-old  girl;  lane  3,  Rickettsia  akari–positive 
control;  lane  4,  R.  rickettsii–positive  control;  lane  5,  R.  typhi–
positive  control.  Bottom:  lane  1,  undigested  17-kDa  gene  PCR 
amplicon; lane 2, 9-year-old girl; lane 3, 32-year-old woman; lane 
4, R. conorii–positive control; lane 5, R. honei–positive control.Human Rickettsialpox, Southeastern Mexico
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